Efficacy and safety of robotic complete mesocolic excision: a systematic review

Int J Colorectal Dis. 2023 Jun 29;38(1):181. doi: 10.1007/s00384-023-04477-8.

Abstract

Background: Complete mesocolic excision (CME) consists of the complete removal of tumor-bearing soft tissues enveloped by the mesocolic fascia and radical lymphadenectomy at the origin of feeding vessels. We conducted a systematic review, evaluating the efficacy of the robotic CME (RCME) in patients with right-sided colon cancer and presenting the data in comparison to those concerning the open RC (right colectomy) with CME.

Methods: One independent researcher searched the MEDLINE-PubMed database for published and unpublished material.

Results: Eighty-three articles were found to refer to CME, 17 of which met the selection criteria following the PRISMA guidelines. All researchers presented short-term outcomes and agreed on the oncologic safety of CME. Different surgical approaches were proposed; however, no significant differences were noticed regarding the peri-operative outcomes.

Conclusion: Although long-term outcomes are needed to establish it as a standard of care in right-sided colon cancer, RCME is a procedure that gains more and more grounds due to its oncologic safety. The standard medial-to-lateral approach seems to have similar results to other approaches.

Keywords: Colon cancer; Complete mesocolic excision; Right-sided colon cancer; Robotic right colectomy.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Colonic Neoplasms* / surgery
  • Humans
  • Lymph Node Excision
  • Mesocolon* / surgery
  • Robotic Surgical Procedures* / adverse effects